Found: 6
Select item for more details and to access through your institution.
Targeted PMP22 TATA-box editing by CRISPR/Cas9 reduces demyelinating neuropathy of Charcot-Marie-Tooth disease type 1A in mice.
- Published in:
- Nucleic Acids Research, 2020, v. 48, n. 1, p. 130, doi. 10.1093/nar/gkz1070
- By:
- Publication type:
- Article
Inhibition of thrombin-induced microglial activation and NADPH oxidase by minocycline protects dopaminergic neurons in the substantia nigra in vivo.
- Published in:
- Journal of Neurochemistry, 2005, v. 95, n. 6, p. 1755, doi. 10.1111/j.1471-4159.2005.03503.x
- By:
- Publication type:
- Article
Small heat shock protein B3 (HSPB3) mutation in an axonal Charcot‐Marie‐Tooth disease family.
- Published in:
- Journal of the Peripheral Nervous System, 2018, v. 23, n. 1, p. 60, doi. 10.1111/jns.12249
- By:
- Publication type:
- Article
Clinical characterization and genetic analysis of Korean patients with X-linked Charcot-Marie-Tooth disease type 1.
- Published in:
- Journal of the Peripheral Nervous System, 2017, v. 22, n. 3, p. 172, doi. 10.1111/jns.12217
- By:
- Publication type:
- Article
X-linked Charcot-Marie-Tooth disease type 6 ( CMTX6) patients with a p. R158H mutation in the pyruvate dehydrogenase kinase isoenzyme 3 gene.
- Published in:
- Journal of the Peripheral Nervous System, 2016, v. 21, n. 1, p. 45, doi. 10.1111/jns.12160
- By:
- Publication type:
- Article
A novel INF2 mutation in a Korean family with autosomal dominant intermediate Charcot-Marie-Tooth disease and focal segmental glomerulosclerosis.
- Published in:
- Journal of the Peripheral Nervous System, 2014, v. 19, n. 2, p. 175, doi. 10.1111/jns5.12062
- By:
- Publication type:
- Article